Amgen (AMGN) Financials
Amgen (AMGN) Historical Financial Statements and Key Metrics for 1989 - 2020
Full Amgen financials for 1989 - 2020 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Amgen Income Statements
(in $ 000,000's)
Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
2020-Dec-31 | 6,634 | 5,037 (75.9 %) | 2,008 (30.3 %) | 1,615 (24.3 %) | 2,881 | 2.76 |
2020-Sep-30 | 6,423 | 4,862 (75.7 %) | 2,453 (34.3 %) | 2,021 (31.5 %) | 3,409 | 3.43 |
2020-Jun-30 | 6,206 | 4,718 (76.0 %) | 2,323 (37.4 %) | 1,803 (29.1 %) | 2,667 | 3.05 |
2020-Mar-31 | 6,161 | 4,648 (75.4 %) | 2,355 (38.2 %) | 1,825 (29.6 %) | 2,582 | 3.07 |
2019-Dec-31 | 6,197 | 4,944 (79.8 %) | 2,048 (33.0 %) | 1,703 (27.5 %) | 2,620 | 2.85 |
2019-Sep-30 | 5,737 | 4,701 (81.9 %) | 2,476 (43.2 %) | 1,968 (34.3 %) | 2,586 | 3.27 |
2019-Jun-30 | 5,871 | 4,859 (82.8 %) | 2,678 (45.6 %) | 2,179 (37.1 %) | 2,951 | 3.57 |
Full historical income statements for 1989 - 2020 is included in the
US Historical Financials dataset.
Amgen Balance Sheets
(in $ 000,000's)
Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
2020-Dec-31 | 62,948 | 53,539 | 32,986 | 9,409 | 10,647 |
2020-Sep-30 | 64,637 | 53,678 | 34,287 | 10,959 | 12,360 |
2020-Jun-30 | 65,011 | 54,352 | 34,224 | 10,659 | 11,421 |
2020-Mar-31 | 61,669 | 52,184 | 31,848 | 9,485 | 8,012 |
2019-Dec-31 | 59,707 | 50,034 | 29,903 | 9,673 | 8,911 |
2019-Sep-30 | 59,535 | 48,608 | 29,791 | 10,927 | 20,853 |
2019-Jun-30 | 59,373 | 48,579 | 30,614 | 10,794 | 21,758 |
Full historical balance sheet data for 1989 - 2020 is included in the
US Historical Financials dataset.
Amgen Cash Flow Statements
(in $ 000,000's)
Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
2020-Dec-31 | 2,153 | -5,401 | -4,867 | 1,980 |
2020-Sep-30 | 3,368 | 0 | 0 | 3,233 |
2020-Jun-30 | 2,842 | -2,159 | 775 | 2,684 |
2020-Mar-31 | 2,134 | -230 | -254 | 1,992 |
2019-Dec-31 | 2,514 | -5,963 | -1,929 | 2,326 |
2019-Sep-30 | 3,377 | 5,372 | -2,859 | 3,207 |
2019-Jun-30 | 1,414 | 2,745 | -5,992 | 1,270 |
Full historical cash flow data for 1989 - 2020 is included in the
US Historical Financials dataset.
Amgen Key Valuation and Operating Metrics
Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
2020-Dec-31 | 134,503 | 161,223 | 20.27 | 83.28 | 14.30 |
2020-Sep-30 | 148,684 | 177,066 | 23.15 | 73.57 | 13.57 |
2020-Jun-30 | 138,700 | 163,688 | 22.35 | 76.93 | 13.01 |
2020-Mar-31 | 118,816 | 141,137 | 19.29 | 65.10 | 12.53 |
2019-Dec-31 | 140,999 | 161,912 | 22.75 | 82.79 | 14.58 |
2019-Sep-30 | 113,376 | 129,703 | 19.76 | 57.61 | 10.38 |
2019-Jun-30 | 109,854 | 132,127 | 18.71 | 50.41 | 10.18 |
Full historical valuation and operating metrics for 1989 - 2020 are included in the
US Historical Financials dataset.